Report updated May 20, 2026
Moje léčba od EUC
For chronically ill patients with cardiometabolic diagnoses, such as Type 2 diabetes, hypertension, or dyslipidemia, under the care of EUC specialists.
Overview · Full Intel report in progress
Moje léčba od EUC is an established medical app that is completely free. With a 5.0/5 rating from 3 reviews, it shows polarized user reception.
What is Moje léčba od EUC?
Current Momentum
v2026.134 · today
IntenseLast updated 0d ago. 5 versions tracked.
Competition
Rivals identification in progress
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Provides a personal timetable to help patients maintain compliance with their prescribed treatment regimen.
Maintains a list of recommended examinations along with dates for both scheduled and completed appointments.
Displays target values for key laboratory and measured health metrics to allow for progress monitoring.
How much does it cost?
Who Built It?
Enrichment in progress
Publisher profile available very soon
What other apps does EUC make?
Analysis in progress, available soon
What do users think recently?
Analysis in progress, available soon
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
Analysis in progress, available soon
What is the competitive landscape for Moje léčba od EUC?
Where is it available?
Localized markets (1)
How's The Medical Market?
How does it evolve in the Medical market?
Rank progression
1 active ranking tracked — 30-day window
Which niche is Moje léčba od EUC in?
to manage chronic disease treatment plans
Explore the full Diabetes Management Trackers niche
Every app in this space — 46 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
Strategic analysis coming soon
SWOT, key takeaways & outlook
The outtake for Moje léčba od EUC
Key Takeaways
The app functions as a centralized digital companion for patients to track their adherence to EUC-specific cardiometabolic treatment plans.
Where Is It Heading?
Trend analysis
Available very soon